Skip to content

California · Nonprofit

BIOCOM INSTITUTE

BIOCOM INSTITUTE (California) receives grants from 22 organizations whose IRS filings report $1,640,950 to it, the largest being Illumina Corporate Foundation ($1,317,950). 13 of them have funded it in more than one year.

Revenue FY2024
$1.4M
Funders on record
22
Grants received
$1.6M
Net assets
$300k
13/22 repeat funderspeak grant-dependency 25%
01What it does

What Biocom Institute does

Mission

Biocom california institute is a 501(c)(3) organization established in 2008 by biocom california, the largest and most experienced advocate for california's life science sector. Our mission is to develop and promote a skilled and diverse pipeline of talent to accelerate the growth of california's life science ecosystem.

As stated on its FY2024 Form 990.

Programs

  1. Novaworks: this agreement establishes a partnership between the city of sunnyvale's nova workforce boardand biocom california institute to deliver life science industry workforce development servicesunder the workforce innovation and opportunity act. The partnership focuses on three keycomponents: (1) supporting life science companies adjusting their workforce size through workeradjustment and retraining notification (warn) assistance, (2) facilitating business and job seekerengagement through industry events and webinars, and (3) implementing a career explorationfellowship program connecting job seekers with mentors and training opportunities. The totalfunding for this partnership is $150,000 for the period from july 31, 2024, through july 30, 2025. Theagreement represents a continuation of workforce development eorts aimed at enhancing novaworkforce services' connections to life science industry employers and improving employmentoutcomes for job seekers.

    $17,577 spent$204,625 earned by the program
    2% of program spending
  2. This agreement establishes a partnership between the verdugo workforce development board(vwdb) and biocom california institute to deliver life science industry workforce developmentservices. The partnership focuses on two key components: (1) implementing a career explorationfellowship program and (2) supporting the growth and enhancement of the Biocom Institutetechnician certification (biotc).the fellowship program will connect job seekers with mentors and training opportunities throughactivities including program planning, customized marketing materials development, applicationprocessing, mentor-fellow matching, event coordination (orientation, career panels, meet and greetevents), and program monitoring with surveys and check-ins.the biotc program involves collaboration with the vwdb, grifols biologicals llc, and los angelesvalley college to expand this industry-recognized credential program to support workforcedevelopment in the life sciences sector. This includes technical assistance to enhance thecredential's reach and implementation.the agreement represents a strategic workforce development initiative aimed at strengtheningconnections between job seekers and life science…

    $87,664 spent$159,152 earned by the program
    8% of program spending
  3. This agreement establishes a partnership between the national institute for innovation inmanufacturing biopharmaceuticals (niimbl), santa clara university (scu), biocom californiainstitute, merck sharp & dohme llc, and genentech to develop and implement the "biocad dataprogramming for biomanufacturing scale-up" project. Running from january 1, 2025 through june30, 2026, the project focuses on four key components:1. Building dissemination channels by implementing biocad with cohorts of industryparticipants including 100 genentech interns, 10 merck employees, 20 biocom student andveteran fellows, and 20+ retraining workers, while launching the biocad intermediate dataprogramming for biomanufacturing certificate nationally.2. Developing primers and intermediate courses in downstream processes analytics includingstatistical methods and biomanufacturing process data programming.3. Creating and evaluating intermediate data programming problems and advanced cases forcomplex end-to-end manufacturing scenarios, with 6-8 hands-on problems and advancedcases focusing on emerging biopharmaceutical manufacturing modalities.4. Adapting biocad materials for community college instructors and…

    $3,241 spent$10,569 earned by the program
    0% of program spending
  4. Remaining other - amgen, contracosta, lsxp, and lsyl

    $971,324 spent$1,065,038 earned by the program
    90% of program spending

The 4 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $1,079,806.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($1.2M) Expenses 100 ($1.2M) Net assets -72 ($-56837)2018 Revenue 87 ($1.0M) Expenses 106 ($1.3M) Net assets -443 ($-351415)2019 Revenue 124 ($1.5M) Expenses 119 ($1.4M) Net assets -294 ($-233096)2020 Revenue 146 ($1.8M) Expenses 151 ($1.8M) Net assets -316 ($-250299)2021 Revenue 161 ($1.9M) Expenses 124 ($1.5M) Net assets 100 ($79k)2022 Revenue 143 ($1.7M) Expenses 121 ($1.5M) Net assets 471 ($374k)2023 Revenue 68 ($815k) Expenses 91 ($1.1M) Net assets 170 ($135k)2024 Revenue 117 ($1.4M) Expenses 104 ($1.2M) Net assets 378 ($300k)
'17'18'19'20'21'22'23'24
Revenue (117)Expenses (104)Net assets (378)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2022 to 2023, from $713k to $285k (−60%).

$603k
$486k
$586k
$780k
$372k
$713k
$285k
$403k
'17'18'19'20'21'22'23'24
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2017 11% · 2018 12% · 2019 3% · 2020 5% · 2021 12% · 2022 16% · 2023 41% · 2024 30%. Grants only. Government contracts and fees sit inside program revenue.

100% of BIOCOM INSTITUTE’s revenue is contributions — more reliant on donations than three-quarters of its peers (67% for the typical peer).

This organization
Typical peer · 498 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 8 reported years ran a deficit.

$328
’17
−$233k
’18
$62k
’19
−$55k
’20
$452k
’21
$256k
’22
−$277k
’23
$165k
’24
3.4
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Chief executive

Joseph D Panetta

President & CEO

As listed on its FY2024 Form 990.

'17'18'19'20'21'22'23'24
Listed8876710119
Joined·+0+3+0+4+4+2+0
No longer listed·0413112
03Who funds it

Who funds it, year by year

2017 → 2023: the base broadened from 2 funders to 5 funders, grant income fell $105k → $42k.

2 of 22 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 2% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

Left out of every figure on this page: $223k from 3 payers (the payer shares this organization's board, largest The San Diego Foundation). These are real filings, and they are not money BIOCOM INSTITUTE raised.

From the IRS filings of BIOCOM INSTITUTE’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

BIOCOM INSTITUTE leans on a few funders — its largest provides 80% of grant income and the top three 87%; half comes from just 1 funder.

the vertical line marks half of all grant income — 1 funder to its left

80%
largest funder
87%
top three
~2
effective funders

Largest funder’s share by year: 2017 95% · 2018 89% · 2019 33% · 2020 91% · 2021 87% · 2022 71% · 2023 36% — diversifying over time.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

31% of BIOCOM INSTITUTE's funders are still giving 3 years after their first grant; 59% give in more than one year at all.

first grant+1y+2y+3y+4y+5y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

BIOCOM INSTITUTE draws 86% of its grant income from funders outside California, across 9 states in all.

NY
MA
NV
OH
NJ
CA
MO
DE
NC

In-state vs out-of-state, by year

’17
’18
’19
’20
’21
’22
’23
California out of state home

Funder states come from each funder’s own filing. $25k arriving through sponsors registered in 2 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

BIOCOM INSTITUTE runs a healthier operating margin than half of the 482 science & tech nonprofits its size.

Operating margin12% · above the median
Months of reserve3.4mo · below the median
Revenue growth (annualized)2% · below the median

this organization peer median middle 50% of peers· 482 science & tech nonprofits $1M–$10M, FY2024

Organizations like BIOCOM INSTITUTE

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In California

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

87% of spending goes to programs.

Program 87%Management 13%Fundraising 0%

Governance

9
board members
100%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990✓Audited financials

Public support

47%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 1 state

CA

Part of a family of 3 related entities

  • Biocom California · exempt
  • Generation Steam · exempt
  • Biocom Purchasing Group · corp_trust

Screen this organization

A dated, signed PDF of the compliance screen for BIOCOM INSTITUTE: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds BIOCOM INSTITUTE?
BIOCOM INSTITUTE (California) receives grants from 22 organizations whose IRS filings report $1,640,950 to it, the largest being Illumina Corporate Foundation ($1,317,950). 13 of them have funded it in more than one year.
How many funders does BIOCOM INSTITUTE have?
IRS filings report 22 organizations giving $1,640,950 in grants to BIOCOM INSTITUTE, 13 of which have funded it in more than one year.
Who is the largest funder of BIOCOM INSTITUTE?
Illumina Corporate Foundation is the largest funder on record, with $1,317,950 in grants. The full list of funders is on this page.
How can an organization like BIOCOM INSTITUTE find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

Play a game about who funds Biocom Institute →

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 22 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing